OMI - Owens & Minor, Inc.

NYSE - NYSE Delayed Price. Currency in USD
3.4000
+0.0200 (+0.59%)
At close: 4:02PM EDT

3.4000 0.00 (0.00%)
After hours: 4:24PM EDT

Stock chart is not supported by your current browser
Previous Close3.3800
Open3.3800
Bid3.3600 x 2900
Ask3.4000 x 3200
Day's Range3.2850 - 3.4000
52 Week Range3.2850 - 19.1600
Volume763,477
Avg. Volume1,735,182
Market Cap214.274M
Beta (3Y Monthly)2.51
PE Ratio (TTM)N/A
EPS (TTM)-7.2820
Earnings DateMay 7, 2019
Forward Dividend & Yield0.01 (0.16%)
Ex-Dividend Date2019-03-14
1y Target Est5.63
Trade prices are not sourced from all markets
  • Business Wire7 hours ago

    Owens & Minor will Report First Quarter 2019 Financial Results on Tuesday, May 7, 2019

    Management will host a conference call to discuss results at 8:30 a.m. EDT on May 7

  • Markit15 days ago

    See what the IHS Markit Score report has to say about Owens & Minor Inc.

    Owens & Minor Inc NYSE:OMIView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is high and has been increasing * Economic output in this company's sector is expanding Bearish sentimentShort interest | NegativeShort interest is high for OMI with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting OMI. Sentiment has worsened and traders added to their bearish short positions on April 1. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding OMI are favorable with net inflows of $73.59 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire16 days ago

    Owens & Minor Names Jeffrey Jochims as Executive Vice President, Strategy & Solutions

    Today, Owens & Minor Inc. (OMI) announced the appointment of Jeffrey Jochims as Executive Vice President, Strategy & Solutions, effective April 8, 2019. Jochims, formerly a long-tenured executive at Thermo Fisher Scientific, joins the company with more than 25 years of business strategy and operations experience focused on distribution, manufacturing, and services in the healthcare, biopharmaceutical, and life sciences research industries. “We are delighted to bring someone with Jeff’s experience to our team,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.

  • GlobeNewswire23 days ago

    Report: Exploring Fundamental Drivers Behind Coeur Mining, Owens & Minor, Telenav, Cedar Realty Trust, j2 Global, and United Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, April 01, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Moody's26 days ago

    Owens & Minor Medical, Inc. -- Moody's downgrades Owens & Minor's CFR to B2; outlook is stable

    Moody's Investors Service ("Moody's") downgraded Owens & Minor, Inc.'s Corporate Family Rating (CFR) to B2 from B1 and the Probability of Default Rating (PD) to B2-PD from B1-PD. Moody's also downgraded the ratings on the senior secured credit facilities and notes to B2 from B1. Concurrently, Moody's affirmed the SGL-3 Speculative Grade Liquidity Rating, signifying adequate liquidity.

  • Levin Capital and Other Hedge Funds Are Snapping Up Farmer Brothers Co. (FARM)
    Insider Monkeylast month

    Levin Capital and Other Hedge Funds Are Snapping Up Farmer Brothers Co. (FARM)

    As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent […]

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of OMI earnings conference call or presentation 20-Feb-19 1:30pm GMT

    Q4 2018 Owens & Minor Inc Earnings Call

  • Benzinga2 months ago

    Healthcare Logistics Company Owens & Minor Explores Sale After Earnings Misses

    Owens & Minor (NYSE: OMI), a healthcare logistics company, is exploring a sale of itself after a series of disappointing earnings reports, according to sources quoted by Reuters in an exclusive report. The $420 million company, by market capitalization, lost 20 percent of its stock value this week after it failed to hit analysts' targets, Reuters reported. It is currently trading at just over five times earnings, according to market data.

  • Moody's2 months ago

    Owens & Minor Medical, Inc. -- Moody's places Owens & Minor's ratings under review for downgrade

    Moody's Investors Service ("Moody's") placed the ratings of Owens & Minor, Inc. ("OMI") on review for downgrade. This includes OMI's B1 Corporate Family Rating, its B1-PD Probability of Default Rating, and the B1 ratings on its senior secured bank facilities and senior secured notes. "The review for downgrade reflects the company's weak operating performance and free cash flow, as well as recent turnover in senior management" stated Jean-Yves Coupin, VP-Senior Analyst at Moody's. "These factors have contributed to financial leverage which is high for the B1 rating category", added Coupin.

  • Reuters2 months ago

    Healthcare logistics company Owens & Minor explores sale: sources

    The Richmond, Virginia-based company's shares tumbled as much as 20 percent on Wednesday, the day after it reported fourth-quarter earnings that missed analysts' expectations amid fierce price competition in its hospital supplies business. Owens & Minor, which has a market capitalization of $420 million, is working with investment banks to explore a sale, said the sources, who asked not to be named because the matter is confidential. Owens & Minor did not respond to a request for comment.

  • MarketWatch2 months ago

    Owens & Minor's stock tumbles after dividend slashed to a penny, earnings miss

    Shares of Owens & Minor Inc. tumbled 14% in active afternoon trade Wednesday, after the provider of distribution services to makers of healthcare products reported fourth-quarter earnings that missed expectations, provided a downbeat outlook and slashed its dividend to next to nothing. The company said late Tuesday it swung to a net loss of $261.8 million, or $4.37 a share, from a profit of $23.0 million, or 38 cents a share, in the same period a year ago. Excluding non-recurring items, such as $274 million impairment charge, adjusted earnings per share of 9 cents was below the FactSet consensus of 14 cents. Revenue rose 6.4% to $2.54 billion, above the FactSet consensus of $2.50 billion. The company said it amended its credit agreements, that while enhances it financial "flexibility," also increases its interest expense. With that in mind, the company expects 2019 adjusted EPS of 60 cents to 75 cents, below the current FactSet consensus of 93 cents. The company also cut its quarterly dividend to 0.25 cents a share from 7.5 cents a share, which lowers the implied annual dividend yield to 0.15% from 4.39%. Separately, Owens & Minor named Edward Pasicka its chief executive officer, effective March 4. The stock has plunged 56% over the past 12 months, while the S&P 500 has gained 2.5%.

  • Owens & Minor Inc (OMI) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    Owens & Minor Inc (OMI) Q4 2018 Earnings Conference Call Transcript

    OMI earnings call for the period ending December 31, 2018.

  • Why Owens & Minor Shares Are Tanking Today
    Motley Fool2 months ago

    Why Owens & Minor Shares Are Tanking Today

    Investors were disappointed by the company's lackluster Q4 earnings update.

  • Associated Press2 months ago

    Owens & Minor: 4Q Earnings Snapshot

    The Mechanicsville, Virginia-based company said it had a loss of $4.37 per share. Earnings, adjusted for asset impairment costs and costs related to mergers and acquisitions, came to 9 cents per share. ...

  • Business Wire2 months ago

    Owens & Minor Reports 4th Quarter & Full-Year 2018 Financial Results

    Owens & Minor, Inc. today reported financial results for the fourth quarter and the year ended December 31, 2018, as summarized in the table shown below.

  • Business Wire2 months ago

    Owens & Minor Declares 1st Quarter 2019 Dividend

    Owens & Minor, Inc. today announced that its Board of Directors has approved a first quarter dividend payment of $0.0025 per share. This dividend is payable on March 29, 2019, to shareholders of record as of March 15, 2019.

  • Owens & Minor Names Ed Pesicka President and Chief Executive Officer
    Business Wire2 months ago

    Owens & Minor Names Ed Pesicka President and Chief Executive Officer

    Owens & Minor Inc. (OMI) today announced that its Board of Directors has named Edward A. Pesicka President and Chief Executive Officer, effective March 4, 2019. Pesicka, a formerly long-tenured executive at Thermo Fisher Scientific, joins the Company with over 25 years of business and operational experience focused on distribution, manufacturing and service for the healthcare, pharmaceutical, biotechnology and scientific research industries. “The Board is extremely pleased to welcome Ed as the new CEO of Owens & Minor,” said Robert Sledd, Chairman and Interim President and Chief Executive Officer.

  • Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for
    Zacks2 months ago

    Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for

    Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire2 months ago

    Owens & Minor will Report Fourth Quarter & Full Year 2018 Financial Results on Wednesday, February 20, 2019

    Management’s conference call to discuss results planned for 8:30 a.m. EST on February 20

  • Earnings Preview: Owens & Minor (OMI) Q4 Earnings Expected to Decline
    Zacks3 months ago

    Earnings Preview: Owens & Minor (OMI) Q4 Earnings Expected to Decline

    Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire3 months ago

    Report: Exploring Fundamental Drivers Behind Realty Income, United Therapeutics, NxStage Medical, PTC Therapeutics, AVEO Pharmaceuticals, and Owens & Minor — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Jan. 28, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.